ENLTM
with DeltaFolateTM plus adenosylcobalamin
[50 mg CBl] [15 mg DFE Folate]
JAYMAC Pharmaceuticals, LLC
Softgels (30ct bottle)
Medical FoodFor Therapeutic Use
Description
ENLTM is a medical food for use under medical supervision to assist MTHFr patients in the clinical dietary managemetnn of depression and is specially formulated to meet the distinctive nutritional requirement for these patients.
Each ENLTM capsule contains 15 mg DFE of reduced folates from DeltaFolateTM plus adenosylcobalamin.
A recent study+ suggested that EnLyte® was effective in lowering homocystine levels in patients that are positive for MTHFR (methylenetetrahydrofolate reductase polymorphism).
+ClinicalTrials.gov identifier: NCT02709668, Correlation of Clinical Response With Homocysteine Reduction During Therapy With Reduced B Vitamins in Patients with MDD Who Are Posititive for MTHFR C677T or A1298C Polymorphism.
OTHER INGREDIENTS: Annatto [colorant], 500 mcg betaine (trimethylglycine), at least 5.5 mg citrates (at least 1.83 mg citric acid, at least 3.67 mg sodium citrates), 25 mcg flavin adenine dinucleotide (reduced vitamin B2), cysteinated ferrous chelate (1.5 mg elemental iron), gelatin (bovine), glycerine, 1 mg magnesium l-threonate, 25 mcg nicotinamide adenine dinucleotide hydride (reduced vitamin B3), piperine, plant lipids (sunflower), purified water, 25 mcg pyridoxal 5’ phosphate (reduced vitamin B6), 25 mcg thiamine pyrophosphate (reduced vitamin B1), ubidecarenone, yellow beeswax. [Coenzyme B12 is the primary form most found in mammalian liver. 2Vitamer of B12 cofactor, l-methylfolate. 3Pure amino acid, cysteinated iron chelate. 4 30% daily value (DV) of VITAMIN C, and 10% DV IRON for geriatrics. 5 Contains at least 12 mg phosphatidylserine (PS)– of which approximately 6.4 mg as PS-DHA-Ca, and less than 1% EPA (<800 mcg PS-EPA-Ca).]
CONTAINS FISH/KRILL/SOY. No artificial colorants. No dairy, wheat, sugar or egg.
ADVERSE REACTIONS:
Mild transient diarrhea, polycythemia vera, itching, transitory exanthema, feeling of swelling of entire body may occur with administration of vitamin B12. Allergic sensitization has been reported following both oral and parenteral administration of vitamin B9.
PRECAUTIONS:
0.1 mg or more of vitamin B9 daily may obscure pernicious anemia in that the hematological remission may occur while neurological manifestations remain progressive. Exclusive use of vitamin B9 in treating vitamin B12-deficient macrocytic anemia could result in progressive and irreversible neurological damage. Specifically, vitamin B12 deficiency allowed to progress over 3 months may produce permanent degenerative lesions of the spinal cord - as observed when vitamin B9 therapy is used as the only hematopoietic agent. Doses of vitamin B12 exceeding 10 mcg daily may produce hematologic response in patients with vitamin B9 deficiency. Indiscriminate administration may mask the true diagnosis. A dietary deficiency of only vitamin B12 is rare; multiple vitamin deficiency is expected in any dietary deficiency. No single regimen fits all cases, and the status of the patient observed in follow-up is the final criterion for adequacy of therapy.
DOSAGE AND ADMINISTRATION:
The adult dose is one capsule daily preferably on an empty stomach.
Call your medical practitioner about side effects.You may report side effects by calling 337.662-5962.
KEEP THIS OUT OF THE REACH OF CHILDREN.
Do not exceed the recommended dose.
